Boehringer Ingelheim posts more Jardiance growth as potential US kidney disease approval nears zbecker Tue, 08/01/2023 – 11:10 More: Boehringer Ingelheim posts more Jardiance growth as potential US kidney disease approval nears Source: fierce
read moreMerck still scouting for M&A deals, even after $10.8B takeover of Prometheus kdunleavy Tue, 08/01/2023 – 11:09 More: Merck still scouting for M&A deals, even after .8B takeover of Prometheus Source: fierce
read moreBristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M aliu Tue, 08/01/2023 – 09:49 More: Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for 0M Source: fierce
read moreFirst-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust More: Invizius gets MHRA Approval for H-Guard research Source: News
read moreThe approval involves the roll-out of a non-cancer chronic pain study for up to 5,000 patients More: NHS nod for Celadon cannabis medicine trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals